Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takumi Ito

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[Development of novel cereblon modulators and their target molecules]Takumi Ito
Journal of Biochemistry|December 23, 2023
Protein degraders - from thalidomide to new PROTACsTakumi Ito
Seikagaku. the Journal of Japanese Biochemical Society|March 17, 2011
[Molecular mechanism of thalidomide teratogenicity]Takumi Ito, Hiroshi Handa
International Journal of Hematology|July 28, 2016
Cereblon and its downstream substrates as molecular targets of immunomodulatory drugsTakumi Ito, Hiroshi Handa
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|June 12, 2020
Molecular mechanisms of thalidomide and its derivativesTakumi Ito, Hiroshi Handa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Cereblon as a primary target of IMiDs]Takumi Ito, Hiroshi Handa
Congenital Anomalies|February 22, 2012
Deciphering the mystery of thalidomide teratogenicityTakumi Ito, Hiroshi Handa
Nature|July 2, 2015
Myeloid disease: Another action of a thalidomide derivativeTakumi Ito, Hiroshi Handa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Recent topics in IMiDs and cereblonTakumi Ito, Hiroshi Handa
Frontiers in Cell and Developmental Biology|March 29, 2021
Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative MedicineTomomi Sato, Takumi Ito, Hiroshi Handa
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[Development of novel cereblon modulators and their target molecules]Takumi Ito
Journal of Biochemistry|December 23, 2023
Protein degraders - from thalidomide to new PROTACsTakumi Ito
Seikagaku. the Journal of Japanese Biochemical Society|March 17, 2011
[Molecular mechanism of thalidomide teratogenicity]Takumi Ito, Hiroshi Handa
International Journal of Hematology|July 28, 2016
Cereblon and its downstream substrates as molecular targets of immunomodulatory drugsTakumi Ito, Hiroshi Handa
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|June 12, 2020
Molecular mechanisms of thalidomide and its derivativesTakumi Ito, Hiroshi Handa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Cereblon as a primary target of IMiDs]Takumi Ito, Hiroshi Handa
Congenital Anomalies|February 22, 2012
Deciphering the mystery of thalidomide teratogenicityTakumi Ito, Hiroshi Handa
Nature|July 2, 2015
Myeloid disease: Another action of a thalidomide derivativeTakumi Ito, Hiroshi Handa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Recent topics in IMiDs and cereblonTakumi Ito, Hiroshi Handa
Frontiers in Cell and Developmental Biology|March 29, 2021
Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative MedicineTomomi Sato, Takumi Ito, Hiroshi Handa
Pageof 8